Figure 1
From: Clinical nodal staging scores for prostate cancer: a proposal for preoperative risk assessment
(A) Probability of missing nodal disease as a function of nodes examined in the development cohort of 4770 patients who were treated with radical prostatectomy and bilateral pelvic lymphadenectomy for localised prostate cancer. (B) Probability of missing nodal disease as a function of nodes examined in the validation cohort of 3595 patients who were treated with radical prostatectomy and bilateral pelvic lymphadenectomy for localised prostate cancer.
